Live feed
Filing
SC 13D/A
SC 13D/A0000914208-18-000324·Evofem Biosciences, Inc.
Schedule 13D ownership disclosure
Evofem Biosciences Operations, Inc.
Security class unavailable · CUSIP: 30048L104
Event date: 2018-05-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,590,688
- Percent of class
- 35.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-18-000324
- Form type
- SC 13D/A
- Filer
- Evofem Biosciences, Inc.
- CIK
- CIK 1618835
- Filed
- May 25, 2018
- Reporting period
- May 22, 2018
- Description
- Schedule 13D beneficial ownership